0001236031-17-000005.txt : 20170623 0001236031-17-000005.hdr.sgml : 20170623 20170623071337 ACCESSION NUMBER: 0001236031-17-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170622 FILED AS OF DATE: 20170623 DATE AS OF CHANGE: 20170623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 17926331 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-06-22 0 0000725363 CEL SCI CORP cvm 0001236030 KERSTEN GEERT R 1 1 0 0 Chief Executive Officer Convertible Note 1.69 2017-06-22 4 A 0 147929 250000 A 2017-06-22 2017-12-22 Common Stock 147929 459788 D Series MM Warrants 1.86 2017-06-22 4 A 0 147929 0.01 A 2017-06-22 2022-06-22 Common Stock 147929 607717 D Mr. Kersten participated in an offering and purchased a note in the principal amount of $250,000. Shares issuable upon the conversion of the note will be restricted securities unless registered. Geert Kersten 2017-06-23